Vaccine-Preventable Disease Control in the Western Pacific Region. Mark Jacobs Director, Communicable Diseases

Size: px
Start display at page:

Download "Vaccine-Preventable Disease Control in the Western Pacific Region. Mark Jacobs Director, Communicable Diseases"

Transcription

1 Vaccine-Preventable Disease Control in the Western Pacific Region Mark Jacobs Director, Communicable Diseases

2 Outline Regional goals Disease-specific updates Hepatitis B Measles Polio Rubella Tetanus Remaining challenges 2

3 3

4 Regional goals related to specific vaccine-preventable diseases Hepatitis B: Reduce chronic infection rate among 5-yearolds to less than 1% Japanese encephalitis: To accelerate control Measles: To achieve and sustain measles elimination Polio: Sustain regional polio-free status until global certification; eliminate vaccine-derived poliovirus risk Rubella: Eliminate rubella and prevent congenital rubella syndrome Tetanus: By 2015 to achieve maternal and neonatal tetanus (MNT) elimination 4

5 Hepatitis B goal 64 th WHO WPRO Regional Committee Meeting, October 2013 Resolution WPR/RC64.R5: The Western Pacific Region should aim to reduce HBsAg seroprevalence to less than 1% in 5-year-old children by 2017; Ensure at least 95% coverage of the eligible population at the national level of the hepatitis B vaccination regimen (including the birth dose), and at least 85% coverage in all districts 5

6 Hepatitis B birth dose coverage improvement strategies Increase health facility deliveries Increase hepatitis B education during ANC Increase links with communities and outreach vaccination Use hepatitis B outside the cold chain where needed (with guidelines and NRA approval) 6

7 Hepatitis B vaccination coverage, Western Pacific Region, V a c c i n a t i o n C o v e r a g e ( % ) HepB3 Coverage HepB Birth Dose Coverage 7

8 Status of verification towards reaching the <1% prevalence goal, WPR,

9 Impact of hepatitis B vaccination and birth dose >7 million deaths estimated to have been prevented by hepatitis B vaccination in the Western Pacific Region in the past 25 years deaths prevented by hepatitis B vaccination among children born in 2014 Regional hepatitis B prevalence now estimated to be 0.96% among children in 2012 birth cohort (those who will be 5 years old in 2017) 9

10 Key challenges for hepatitis B Birth dose vaccination coverage is still low in several countries (Lao PDR, Papua New Guinea, the Philippines, Solomon Islands, Viet Nam) Recent hepatitis B related AEFIs led to increased vaccination hesitancy in some countries Even with high coverage, substantial numbers of new infections (50 000) are occurring among new birth cohorts in China 10

11 Goal of measles elimination In 2005, WPRO Regional Committee resolved to achieve measles elimination by 2012 In 2012, WPRO Regional Committee reaffirmed its commitment to eliminate measles as quickly as possible The World Health Assembly endorsement of the Global Vaccine Action Plan includes goals that: By 2015, four of six WHO regions achieve measles elimination By 2020, five of six WHO regions achieve measles elimination 11

12 Key facts on measles elimination Measles is one of the leading causes of death among young children even though a safe and cost-effective vaccine is available In 2013, there were measles deaths globally about 400 deaths every day or 16 deaths every hour Measles vaccination resulted in a 75% drop in measles deaths between 2000 and 2013 worldwide In 2013, about 84% of the world's children received one dose of measles vaccine by their first birthday through routine health services up from 73% in 2000 During , measles vaccination prevented an estimated 15.6 million deaths making measles vaccine one of the best buys in public health 12

13 Key strategies for measles elimination Achieve and maintain high (>95%) coverage with two doses of measles containing vaccine Monitor disease using effective case based surveillance Develop and maintain outbreak preparedness Communicate and engage the community to create demand for vaccination 13

14 Reported Measles Incidence Rate*, Jul 2014 to Jun 2015 *Rate per 1'000'000 population 14 Data source: surveillance DEF file Data in HQ as of 10 August 2015 <1 (73 countries or 38%) 1 - <5 (36 countries or 19%) 5 - <10 (18 countries or 9%) 10 - <50 (30 countries or 15%) 50 (20 countries or 10%) No data reported to WHO HQ Not applicable (17 countries or 9%) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved.

15 Reported confirmed measles cases by month of onset, Jan 2010-Jun 2015, Western Pacific Region 15

16 Summary of Progress Towards Measles Elimination, as assessed by the Regional Verification Commission, March Categories Verified as having achieved elimination <36 months since achieving interruption of endemic measles transmission May be ready for verification but additional information needed Countries, Areas, Epidemiological Blocks Australia, Brunei Darussalam, Cambodia, Japan, Macao (China), Mongolia, Republic of Korea (n=7) New Zealand (n=1) Hong Kong SAR (China), Singapore (n=2) 4 Periods with low/no documented transmission followed by outbreaks Lao People s Democratic Republic, Pacific islands (n=2) 5 Ongoing measles virus transmission China, Malaysia, Papua New Guinea, the Philippines, Viet Nam (n=5) 16

17 Key challenges in measles elimination Measles virus is one of the most (or perhaps the most) infectious of all viruses Very high (>95%) population immunity required Complacency or vaccine hesitancy because measles is considered a benign childhood illness rather than recognized as the fifth leading cause of death among children under 5 years of age Immunity gaps among very young children (eg too young to be vaccinated) and adult populations that missed vaccination and not previously infected 17

18 Goal of polio eradication 1954: Jonas Salk develops a killed polio virus. 1961: Albert Sabin develops an oral polio vaccine World Health Assembly resolved to eradicate polio by 2000

19 Progress on polio eradication 1988: 125 countries; 350,000 cases per year 2015: 2 countries with reported cases; 36 cases year to date 19

20 Progress on polio eradication Poliovirus types Type 1: Ongoing transmission Type 2: Last reported from India in 1999 Type 3: Last reported from Nigeria in 2012 Regional certification of polio-free status 1994: Region of the Americas 2000: Western Pacific Region 2002: European Region 2014: South East Asia Region 2014: Last wild poliovirus case reported from African Region 20

21 Key strategies for polio eradication Poliovirus detection and interruption: Maintaining sensitive surveillance systems worldwide Strengthening immunization systems and withdrawal of OPV: Introduce at least one dose of IPV and switch from topv to bopv Containment and certification: Contain polioviruses and potentially infected waste to prevent accidental reintroduction Legacy planning: Turn over polio programme assets for use in other disease control programmes 21

22 IPV introduction in the Western Pacific Approximate number of live births 2012 (JRF) IPV using country/area Country/area with sequential (IPV/OPV) schedule OPV country/area not GAVI eligible OPV country/area eligible for GAVI support for IPV 22

23 Key challenges for polio eradication Reaching children in insecure border area of Afghanistan and Pakistan where polio workers have been killed Polio eradication is not just the job of polio-infected countries; all countries should Maintain high population immunity Maintain sensitive surveillance for acute flaccid paralysis Very rapid timelines for IPV introduction Identification and containment of all polioviruses and potentially infectious material in all laboratories (private and public) world wide 23

24 Goal of rubella elimination In 2012, World Health Assembly endorsed the Global Vaccine Action Plan goals that: By 2015, two of six WHO regions achieve rubella elimination By 2020, five of six WHO regions achieve rubella elimination In 2013, the Regional Committee for the Western Pacific resolved to eliminate rubella and prevent congenital rubella syndrome (CRS) 24

25 Rubella incidence per million, ,050 2,100 4,200 Kilometers <1 case per million (82 countries or 42%) >1--<5 (21 countries or 11%) >5--<10 (12 countries or 6%) >10--<50 (12 countries or 6%) >= 50 (7 countries or 4%) Not available / No data reported to WHO HQ (60 countries or 31%) Not applicable 25 Source: Joint Reporting Form as at 15 May WHO Member States. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization Date of slide: 15 May 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved

26 Vaccination for rubella in the Western Pacific Region 26 26

27 Regional progress toward rubella elimination Australia, New Zealand, the Republic of Korea and Singapore have been approaching rubella elimination Japan developed and officially issued a national plan and strategy for rubella elimination in 2014 and determined 2020 as target year Mongolia aims to eliminate rubella by 2020 and has started development of a National Strategy for Measles and Rubella Elimination Cambodia will start development of a national plan and strategy for rubella elimination 27

28 Key strategies for rubella elimination Use only combination measles-rubella vaccines for all routine and supplementary doses Monitor rubella disease and occurrence of CRS using sensitive case based surveillance Communicate with and engage community to create demand for vaccination 28

29 Key challenges for rubella elimination Disease control programme is not as well established as measles; many countries do not include rubella as reportable disease Three countries in region have not yet introduced rubella vaccine into routine programme, but are expected to do so by 2016 (Papua New Guinea, Vanuatu, and Viet Nam) In the past, many countries vaccinated only girls, which leaves a large susceptible pool for disease transmission among adult men 29

30 Maternal and Neonatal Tetanus Elimination The World Health Assembly first called for elimination of neonatal tetanus in 1989 In 1999, goal was expanded to include elimination of the maternal tetanus Neonatal tetanus (NT) occurring 28 days of life Maternal tetanus occurring during or 6 weeks following delivery At that time, 57 countries had not eliminated MNT In October 2014, WHO Regional Committee for the Western Pacific endorsed goal of MNT elimination in all countries by

31 Key strategies for MNT Elimination Tetanus toxoid containing vaccine supplementary immunization campaigns for all women of reproductive age in high risk districts Tetanus toxoid containing vaccination of pregnant women Clean delivery and clean umbilical cord care (ideally through skilled birth attendants in health care facility setting) Neonatal tetanus surveillance 31

32 From 2000 to April 2015, 37 countries eliminated MNT *(Plus Ethiopia except Somali Region; 30 of 34 provinces in Indonesia; and 16 of 17 regions in Philippines) Source: WHO/UNICEF Database Date of slide : 26 May 2015 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization ,500 3,000 4,500 6,000 Kilometers MNT not eliminated (N=22) MNT eliminated from April 2015 (N=37) MNT eliminated before 2000 Not Applicable 32

33 MNT elimination in the Western Pacific: Only 6 countries included in list of 59 high risk countries Viet Nam: Validated in 2005 China: Validated in 2012 Lao PDR: Validated in 2013 Philippines: 16/17 regions validated in Feb 2015 Cambodia: Validated in June 2015 Papua New Guinea: Pending LEGEND: Validated 16 of 17 regions validated (Philippines) Not yet validated (Papua New Guinea) 33

34 Key challenges for MNT elimination Philippines: Insecurity in the Autonomous Region of Muslim Mindanao Papua New Guinea: Competing priorities for scarce resources in a setting of developing health care delivery system 34

35 In conclusion Enormous strides made by countries of WPR in tackling VPD Elimination of measles and rubella, and eradication of polio, is within our grasp Some key challenges remain- Expanding coverage in hard to reach groups Maintaining national focus as case numbers drop Retaining community support Balancing opportunities re new vaccines with achieving and sustaining necessary coverage with existing vaccines Reduced donor support for immunisation in some countries, adding to difficulty of maintaining national focus and building on past success 35

36

Expanded Programme on Immunization

Expanded Programme on Immunization Expanded Programme on Immunization Expanded Programme on Immunization has been delivered the immunization services to the targeted children of under one year old child and pregnant women. Currently total

More information

use after global polio eradication

use after global polio eradication WHO/POLIO/05.02 Cessation of routine oral polio vaccine (OPV) use after global polio eradication Framework for National Policy Makers in OPV-Using Countries Index 1. Introduction 2. Rationale for eventual

More information

Securing Polio s Legacy. Transition Planning. Frequently Asked Questions

Securing Polio s Legacy. Transition Planning. Frequently Asked Questions Securing Polio s Legacy Transition Planning March 2015 Frequently Asked Questions Context In May 2013, the 66 th World Health Assembly endorsed the Polio Eradication and Endgame Strategic Plan 2013-2018.

More information

Polio and the Introduction of IPV

Polio and the Introduction of IPV Polio and the Introduction of IPV Poliomyelitis (polio) is a highly infectious disease that is caused when a person is infected by the polio virus that invades the nervous system. Poliomyelitis can cause

More information

Goal 2: Achieve Universal Primary Education

Goal 2: Achieve Universal Primary Education 92 Goal 2: Achieve Universal Primary Education In eight economies in the region including a number from the Pacific, total net enrollment ratios in primary education are below 80%. Eleven economies including

More information

Meeting Report. Twentieth Meeting of the Technical Advisory Group (TAG) on Immunization and Vaccine Preventable Diseases in the Western Pacific Region

Meeting Report. Twentieth Meeting of the Technical Advisory Group (TAG) on Immunization and Vaccine Preventable Diseases in the Western Pacific Region Meeting Report Twentieth Meeting of the Technical Advisory Group (TAG) on Immunization and Vaccine Preventable Diseases in the Western Pacific Region Manila, Philippines 9 12 August 2011 RS/2011/GE/50(PHL)

More information

No Goal Indicator Operational definition Data source/ collection Baseline Target Milestones

No Goal Indicator Operational definition Data source/ collection Baseline Target Milestones No Goal Indicator Operational definition Data source/ collection Baseline Target Milestones G 1.1 Achieve a world free of poliomyelitis Interrupt wild poliovirus transmission globally G1.2 Certification

More information

Summary of GAVI Alliance Investments in Immunization Coverage Data Quality

Summary of GAVI Alliance Investments in Immunization Coverage Data Quality Summary of GAVI Alliance Investments in Immunization Coverage Data Quality The GAVI Alliance strategy and business plan for 2013-2014 includes a range of activities related to the assessment and improvement

More information

Seven Key Reasons Why immunization must remain a priority in the WHO European Region

Seven Key Reasons Why immunization must remain a priority in the WHO European Region Seven Key Reasons Why immunization must remain a priority in the WHO European Region A dramatic decrease in cases of vaccine-preventable diseases has made many infectious diseases seen as a thing of the

More information

MDG 4: Reduce Child Mortality

MDG 4: Reduce Child Mortality 143 MDG 4: Reduce Child Mortality The target for Millennium Development Goal (MDG) 4 is to reduce the mortality rate of children under 5 years old (under-5 mortality) by two-thirds between 1990 and 2015.

More information

POLIO ERADICATION AND ENDGAME STRATEGIC PLAN EXECUTIVE SUMMARY ADVANCES AGAINST POLIO IN 2012 ADVANCE COPY FOR MEDIA

POLIO ERADICATION AND ENDGAME STRATEGIC PLAN EXECUTIVE SUMMARY ADVANCES AGAINST POLIO IN 2012 ADVANCE COPY FOR MEDIA POLIO ERADICATION AND ENDGAME STRATEGIC PLAN EXECUTIVE SUMMARY Since its launch at the World Health Assembly in 1988, the Global Polio Eradication Initiative (GPEI) has reduced the global incidence of

More information

WHO in 60 years: a chronology of public health milestones

WHO in 60 years: a chronology of public health milestones WHO in 60 years: a chronology of public health milestones In 2008, WHO is celebrating its 60 th anniversary. The chronology below tells the story of WHO and public health achievements over the last 60

More information

Haemophilus influenzaetype b (Hib) Vaccination Position Paper. July 2013

Haemophilus influenzaetype b (Hib) Vaccination Position Paper. July 2013 Haemophilus influenzaetype b (Hib) Vaccination Position Paper July 2013 Hib burden-pre vaccine era In 2000, before widespread introduction of Hib vaccine in resource-poor countries, Hib caused: 8.13 million

More information

SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION: MEMBERSHIP OF THE POLICY AND COORDINATION COMMITTEE

SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION: MEMBERSHIP OF THE POLICY AND COORDINATION COMMITTEE W O R L D H E A L T H ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ REGIONAL OFFICE FOR THE WESTERN PACIFIC BUREAU RÉGIONAL DU PACIFIQUE OCCIDENTAL REGIONAL COMMITTEE WPR/RC66/11 Sixty-sixth session 27

More information

Polio Eradication & Endgame Strategic Plan 2013-2018 Executive Summary

Polio Eradication & Endgame Strategic Plan 2013-2018 Executive Summary Polio Eradication & Endgame Strategic Plan 2013-2018 Executive Summary World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site

More information

UNITED NATIONS Economic and Social Commission for Asia and the Pacific 53 member States 9 associate members

UNITED NATIONS Economic and Social Commission for Asia and the Pacific 53 member States 9 associate members UNITED NATIONS Economic and Social Commission for Asia and the Pacific 53 member States 9 associate members South and South-West Asia Afghanistan Bangladesh Bhutan India Iran Maldives Nepal Pakistan Sri

More information

Philippines: PCV Introduction and Experience. Dr. Enrique A. Tayag Assistant Secretary Department of Health Philippines

Philippines: PCV Introduction and Experience. Dr. Enrique A. Tayag Assistant Secretary Department of Health Philippines Philippines: PCV Introduction and Experience Dr. Enrique A. Tayag Assistant Secretary Department of Health Philippines Outline Evidence Communications and Advocacy Role of professional Organizations Role

More information

ICT Development Index (IDI)

ICT Development Index (IDI) ITU Regional Forum and Training Workshop on Telecommunication/ICT Indicators: Measuring the Information Society and ITU ASEAN Meeting on Establishing National ICT Statistics Portals and Measuring ASEAN

More information

Chapter 20: Analysis of Surveillance Data

Chapter 20: Analysis of Surveillance Data Analysis of Surveillance Data: Chapter 20-1 Chapter 20: Analysis of Surveillance Data Sandra W. Roush, MT, MPH I. Background Ongoing analysis of surveillance data is important for detecting outbreaks and

More information

Current Trends in Immunization

Current Trends in Immunization Current Trends in Immunization Christian Lease Director, Immunization Policy, Novartis Vaccines 2011 NCSL Meeting Objectives Review the benefits of immunization Discuss where the immunization enterprise

More information

POLIO ERADICATION AND ENDGAME STRATEGIC PLAN 2013-2018

POLIO ERADICATION AND ENDGAME STRATEGIC PLAN 2013-2018 POLIO ERADICATION AND ENDGAME STRATEGIC PLAN 2013-2018 Global Polio Eradication Initiative 1 ACRONYMS TABLE OF CONTENTS EXECUTIVE SUMMARY 1. STATEMENT OF INTENT 2. BACKGROUND 3. OVERVIEW What s New Major

More information

FINANCIAL RESOURCE REQUIREMENTS

FINANCIAL RESOURCE REQUIREMENTS FINANCIAL RESOURCE REQUIREMENTS 2013-2019 (AS OF 1 APRIL 2016) PARTNERS IN THE GLOBAL POLIO ERADICATION INITIATIVE FINANCIAL RESOURCE REQUIREMENTS 2013-2019 2 FINANCIAL RESOURCE REQUIREMENTS 2013-2019

More information

NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Polio Campaigns

NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Polio Campaigns NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL Polio Campaigns With fewer than 600 days remaining to the Millennium Development Goal (MDG) deadline, new strategies

More information

Measles and rubella monitoring

Measles and rubella monitoring SURVEILLANCE REPORT Measles and rubella monitoring February 213 Measles and rubella are targeted for elimination in Europe by 215. ECDC closely monitors progress towards interruption of endemic transmission

More information

Economic Case for Eradicating Polio

Economic Case for Eradicating Polio Economic Case for Eradicating Polio Summary The Polio Eradication and Endgame Strategic Plan 2013-2018 (The Plan) 1 has been developed to capitalize on a unique opportunity to eradicate a disease only

More information

Viral hepatitis. Report by the Secretariat

Viral hepatitis. Report by the Secretariat SIXTY-THIRD WORLD HEALTH ASSEMBLY A63/15 Provisional agenda item 11.12 25 March 2010 Viral hepatitis Report by the Secretariat THE DISEASES AND BURDEN 1. The group of viruses (hepatitis A, B, C, D and

More information

Child Survival and Equity: A Global Overview

Child Survival and Equity: A Global Overview Child Survival and Equity: A Global Overview Abdelmajid Tibouti, Ph.D. Senior Adviser UNICEF New York Consultation on Equity in Access to Quality Health Care For Women and Children 7 11 April 2008 Halong

More information

International Health Regulations

International Health Regulations International Health Regulations World Health Organization 2008 WHO/CDS/EPR/IHR/2007.2 WHO Lyon Office for National Epidemic Preparedness and Response 58, avenue Debourg, 69007 Lyon, France Tel: +33 (0)4

More information

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND EPIDEMIOLOGY OF HEPATITIS B IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 11 References 12 Epidemiology of Hepatitis

More information

Main Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society January 12, 2014

Main Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society January 12, 2014 Main Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society January, 04 ) 3-valent Pneumococcal conjugate vaccine (PCV3) The description of catch-up schedule for PCV3 has been revised

More information

H1N1 Vaccine Deployment and Vaccination update

H1N1 Vaccine Deployment and Vaccination update H1N1 Vaccine Deployment and Vaccination update Outline Donor Commitments Vaccine Prequalification Country Preparedness Vaccine Deliveries Vaccine utilization and coverage Some lessons learned 2 H1N1 Pandemic

More information

It takes a planet: global implications/consequences of local vaccine refusal

It takes a planet: global implications/consequences of local vaccine refusal It takes a planet: global implications/consequences of local vaccine refusal Meg Fisher, MD Medical Director Disclosures I have no disclosures. I may be mentioning off label uses of vaccines. Objectives/Outcomes

More information

National EPI Review Report

National EPI Review Report National EPI Review Report Vietnam 30 March to 10 April 2009 1 Table of Contents List of Figures and Tables... 3 Acronyms... 4 1. Executive Summary... 5 Key Recommendations... 8 Immunization Services...

More information

XXIII TAG Meeting Varadero, Cuba TABLE OF CONTENTS... 2 TAG MEMBERS... 4 ACRONYMS... 6 INTRODUCTION... 8 REGIONAL IMMUNIZATION ACTION PLAN...

XXIII TAG Meeting Varadero, Cuba TABLE OF CONTENTS... 2 TAG MEMBERS... 4 ACRONYMS... 6 INTRODUCTION... 8 REGIONAL IMMUNIZATION ACTION PLAN... Technical Advisory Group on Vaccine-preventable Diseases (TAG) XXIII Meeting 1-3 July, 2015 Table of Contents TABLE OF CONTENTS... 2 TAG MEMBERS... 4 ACRONYMS... 6 INTRODUCTION... 8 REGIONAL IMMUNIZATION

More information

WHO/UNICEF STRATEGIC PLAN FOR POLIO OUTBREAK RESPONSE THE SYRIAN ARAB REPUBLIC AND SURROUNDING COUNTRIES

WHO/UNICEF STRATEGIC PLAN FOR POLIO OUTBREAK RESPONSE THE SYRIAN ARAB REPUBLIC AND SURROUNDING COUNTRIES WHO/UNICEF STRATEGIC PLAN FOR POLIO THE SYRIAN ARAB REPUBLIC AND SURROUNDING COUNTRIES IRAQ, JORDAN, LEBANON, TURKEY, WEST BANK AND GAZA STRIP, EGYPT DRAFT 26 NOVEMBER 2013 Contents I. EXECUTIVE SUMMARY...

More information

Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action

Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action World Health Organization 2011. All rights reserved. The designations employed and the presentation of the material in this

More information

Children in Egypt 2014 A STATISTICAL DIGEST

Children in Egypt 2014 A STATISTICAL DIGEST Children in Egypt 2014 A STATISTICAL DIGEST CHAPTER 4 IMMUNIZATION AND HEALTH Children in Egypt 2014 is a statistical digest produced by UNICEF Egypt to present updated and quality data on major dimensions

More information

Health, history and hard choices: Funding dilemmas in a fast-changing world

Health, history and hard choices: Funding dilemmas in a fast-changing world Health, history and hard choices: Funding dilemmas in a fast-changing world Thomson Prentice Global Health Histories Health and Philanthropy: Leveraging change University of Indiana, August 2006 An embarrassment

More information

Module 7 Expanded Programme of Immunization (EPI)

Module 7 Expanded Programme of Immunization (EPI) Module 7 Expanded Programme of Immunization (EPI) (including Vitamin A, Tetanus Toxoid and Growth Monitoring) CONTENTS 7.1 What are the tools used for data collection?....................................2

More information

Eradication and Control Programs: A Look at Polio

Eradication and Control Programs: A Look at Polio Eradication and Control Programs: A Look at Polio Tista Ghosh, MD MPH Assistant Clinical Professor University of Colorado March 2009 Prepared as part of an education project of the Global Health Education

More information

http://www.ilga.gov/commission/jcar/admincode/077/077006650b0240...

http://www.ilga.gov/commission/jcar/admincode/077/077006650b0240... 1 of 5 7/30/2014 9:47 AM TITLE 77: PUBLIC HEALTH CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER i: MATERNAL AND CHILD HEALTH PART 665 CHILD HEALTH EXAMINATION CODE SECTION 665.240 BASIC IMMUNIZATION

More information

Report of the 1 st Meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis

Report of the 1 st Meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis Distr.: General Orig.: English Report of the 1 st Meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis Geneva, Switzerland 16-17 February 1995 Expanded Programme on

More information

Risks, risk mitigation and contingency planning

Risks, risk mitigation and contingency planning Risks, risk mitigation and contingency planning 9.1 The Polio Eradication & Endgame Strategic Plan 2013-2018 has been designed to achieve polio eradication taking into account the specific challenges of

More information

Frequently Asked Questions PROPOSED REVISIONS TO SCHOOL IMMUNIZATION REGULATIONS IN PENNSYLVANIA

Frequently Asked Questions PROPOSED REVISIONS TO SCHOOL IMMUNIZATION REGULATIONS IN PENNSYLVANIA Frequently Asked Questions PROPOSED REVISIONS TO SCHOOL IMMUNIZATION REGULATIONS IN PENNSYLVANIA What is the current school vaccination rate in Pennsylvania? Given the way in which data is collected, we

More information

Prepared as a contribution to Sanitation and Water 2008 A World Vision/AusAid Conference October 27-29, 2009 Melbourne, Australia

Prepared as a contribution to Sanitation and Water 2008 A World Vision/AusAid Conference October 27-29, 2009 Melbourne, Australia A Snapshot of Drinking Water and Sanitation in South-eastern Asia and the Pacific A regional perspective based on the 2008 Report of the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation

More information

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15

More information

INDICATOR REGION WORLD

INDICATOR REGION WORLD SUB-SAHARAN AFRICA INDICATOR REGION WORLD Demographic indicators Total population (2005) 713,457,000 6,449,371,000 Population under 18 (2005) 361,301,000 2,183,143,000 Population under 5 (2005) 119,555,000

More information

Senate Committee: Education and Employment. QUESTION ON NOTICE Budget Estimates 2015-2016

Senate Committee: Education and Employment. QUESTION ON NOTICE Budget Estimates 2015-2016 Senate Committee: Education and Employment QUESTION ON NOTICE Budget Estimates 2015-2016 Outcome: Higher Education Research and International Department of Education and Training Question No. SQ15-000549

More information

STRATEGIC PLAN 2010-15

STRATEGIC PLAN 2010-15 DRAFT: 24 March 2010 STRATEGIC PLAN 2010-15 DEPARTMENT OF IMMUNIZATION, VACCINES AND BIOLOGICALS 1 IVB Strategic Plan 2010-15 Contents Foreword 1. Introduction 1.1 Context of this Strategic Plan 1.2 Analysis

More information

ASIA AND PACIFIC VEHICLE STANDARDS & FLEETS

ASIA AND PACIFIC VEHICLE STANDARDS & FLEETS ASIA AND PACIFIC VEHICLE STANDARDS & FLEETS 14 vehicles per 1000 people (), up from 11 in 1990 Afghanistan Bangladesh Bhutan Brunei Darussalam Cambodia less than three years old. Importation of used vehicles

More information

TESTING AND MANAGEMENT. Dr Nicole Allard GP Cohealth, Joslin Clinic, West Footscray PhD student, Epidemiology Unit VIDRL

TESTING AND MANAGEMENT. Dr Nicole Allard GP Cohealth, Joslin Clinic, West Footscray PhD student, Epidemiology Unit VIDRL TESTING AND MANAGEMENT Dr Nicole Allard GP Cohealth, Joslin Clinic, West Footscray PhD student, Epidemiology Unit VIDRL Disclosure and acknowledgments No conflicts of interest Board Member of Hepatitis

More information

GLOBAL IMMUNIZATION NEWS

GLOBAL IMMUNIZATION NEWS GLOBAL IMMUNIZATION NEWS The information contained in this Newsletter depends upon your contributions Please send inputs for inclusion to: nicolash@who.int 28 March 2008 TECHNICAL INFORMATION CAPACITY

More information

GLOSSARY ABTC APEC API ASEAN

GLOSSARY ABTC APEC API ASEAN GLOSSARY ABTC APEC Business Travel Card Card used by business travellers from APEC member countries to enable visa-free travel between APEC countries and expedited processing at immigration checkpoints.

More information

Immunization Infrastructure: The Role of Section 317

Immunization Infrastructure: The Role of Section 317 Immunization Infrastructure: The Role of Section 317 Immunization plays a vital role in the control and prevention of infectious disease. Current immunization recommendations target 17 vaccine-preventable

More information

WHO HEALTH EMERGENCY PROGRAMME RESULTS FRAMEWORK AND BUDGET REQUIREMENTS 2016-2017 16 May 2016

WHO HEALTH EMERGENCY PROGRAMME RESULTS FRAMEWORK AND BUDGET REQUIREMENTS 2016-2017 16 May 2016 PURPOSE WHO HEALTH EMERGENCY PROGRAMME RESULTS FRAMEWORK AND BUDGET REQUIREMENTS 2016-2017 16 May 2016 Financing the work of the new WHO Health Emergencies Programme will require a combination of core

More information

Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme

Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme Change to DENMARK S CHILDHOOD VACCINATION PROGRAMME 2014 Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme 2014 Addition to the Danish Health and Medicines

More information

Expanded Program on Immunisation (EPI)

Expanded Program on Immunisation (EPI) Expanded Program on Immunisation (EPI) Infant mortality and under five mortality rates in Ethiopia are among the highest in the world. Diarrhoeal diseases, vaccine preventable diseases (VPDs) and malnutrition

More information

Vaccination: It s what your child would choose. Your guide to childhood vaccinations.

Vaccination: It s what your child would choose. Your guide to childhood vaccinations. Vaccination: It s what your child would choose No-one likes an injection, but your child would never choose to suffer from serious conditions like measles, mumps or whooping cough. Your guide to childhood

More information

Surveillance System in the Philippines

Surveillance System in the Philippines Surveillance System in the Philippines Outline 1. Brief Background Information IHR Surveillance Systems in the Philippines 2. Surveillance and Response for EVD Our world is changing as never before Populations

More information

THE NEW DELHI DECLARATION ON SOUTH-SOUTH COOPERATION FOR CHILD RIGHTS IN ASIA AND THE PACIFIC

THE NEW DELHI DECLARATION ON SOUTH-SOUTH COOPERATION FOR CHILD RIGHTS IN ASIA AND THE PACIFIC THE NEW DELHI DECLARATION ON SOUTH-SOUTH COOPERATION FOR CHILD RIGHTS IN ASIA AND THE PACIFIC We, the delegations of the governments of Afghanistan, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, China,

More information

Internet infrastructure development in the Asia Pacific: What s needed for sustainable growth

Internet infrastructure development in the Asia Pacific: What s needed for sustainable growth Internet infrastructure development in the Asia Pacific: What s needed for sustainable growth Miwa Fujii , Senior Advisor Internet Development, APNIC 29 th April 2014 ADB/ITU ICT Development

More information

Measles-Containing Vaccines: Supply & Demand Outlook. UNICEF Supply Division

Measles-Containing Vaccines: Supply & Demand Outlook. UNICEF Supply Division Measles-Containing Vaccines: Supply & Demand Outlook UNICEF Supply Division July 2015 0 Measles-Containing Vaccines: Supply & Demand Outlook July 2015 This informational note summarises the demand and

More information

7. Laws IN THIS SECTION INTRODUCTION

7. Laws IN THIS SECTION INTRODUCTION 7. Laws IN THIS SECTION Missouri Immunization Statutes and Rules Missouri s School Immunization Statute and Rule (RSMo 167.181) Missouri s Child Care Immunization Statute and Rule (RSMo 210.003) Blood

More information

Report of the 28th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication

Report of the 28th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication Report of the 28th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication Copenhagen, Denmark 3 5 June 2014 ABSTRACT The 28th Meeting of the European Regional Certification

More information

The shaded areas of the map represent ESCAP members and associate members.

The shaded areas of the map represent ESCAP members and associate members. ESCAP is the regional development arm of the United Nations and serves as the main economic and social development centre for the United Nations in Asia and the Pacific. Its mandate is to foster cooperation

More information

4 GOAL 4. Reduce child mortality Reduce by two-thirds, between 1990 and 2015, the under-five mortality rate

4 GOAL 4. Reduce child mortality Reduce by two-thirds, between 1990 and 2015, the under-five mortality rate ACHIEVING THE HEALTH RELATED MDGS IN THE WESTERN PACIFIC REGION 2010 PROGRESS REPORT III Progress towards MDGs 4, 5 and 4 5 This chapter addresses the three MDGs and their targets that are most directly

More information

Summary report. Meeting of the Regional Technical Advisory Group (RTAG) on immunization of the WHO Eastern Mediterranean Region

Summary report. Meeting of the Regional Technical Advisory Group (RTAG) on immunization of the WHO Eastern Mediterranean Region Summary report Meeting of the Regional Technical Advisory Group (RTAG) on immunization of the WHO Eastern Mediterranean Region Amman, Jordan, 21 November 2013 Introduction The annual Meeting of the Regional

More information

PAVE 2016 Internships

PAVE 2016 Internships PAVE 2016 Internships I. World Health Organization, Immunization, Vaccines, and Biological Division (WHO IVB) 1. Development of surveillance standards for typhoid and other invasive salmonellosis 2. Cost

More information

Childhood Immunization Status (CIS)

Childhood Immunization Status (CIS) Childhood Immunization Status (CIS) Description The percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV); one measles, mumps and rubella

More information

INDICATOR REGION WORLD

INDICATOR REGION WORLD SUB-SAHARAN AFRICA INDICATOR REGION WORLD Demographic indicators Total population (2006) 748,886,000 6,577,236,000 Population under 18 (2006) 376,047,000 2,212,024,000 Population under 5 (2006) 125,254,000

More information

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Questions and Answers May 2014 Health Protection Scotland

More information

Gregory S. Wallace, James P. Alexander, Steven G. F. Wassilak

Gregory S. Wallace, James P. Alexander, Steven G. F. Wassilak Chapter 3 - Pneumococcal Disease (/travel/yellowbook/2014/chapter-3-infectious-diseases-relatedto-travel/pneumococcal-disease) Chapter 3 - Q Fever (/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/q-fever)

More information

Containing Pandemic and Epidemic Diseases in Asia

Containing Pandemic and Epidemic Diseases in Asia Containing Pandemic and Epidemic Diseases in Asia EXECUTIVE SUMMARY How prepared is Asia for pandemic and epidemic diseases? While efforts by national governments and international organizations to prevent

More information

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item 12.3 24 May 2014. Hepatitis

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item 12.3 24 May 2014. Hepatitis SIXTY-SEVENTH WORLD HEALTH ASSEMBLY WHA67.6 Agenda item 12.3 24 May 2014 Hepatitis The Sixty-seventh World Health Assembly, Having considered the report on hepatitis; 1 Reaffirming resolution WHA63.18,

More information

english facts about hepatitis A, B and C

english facts about hepatitis A, B and C english facts about hepatitis A, B and C What is hepatitis? Hepatitis means inflammation of the liver. Many viruses can cause liver inflammation, including the hepatitis A, B and C viruses. Some people

More information

WHO Regional Office for Europe update on avian influenza A (H7N9) virus

WHO Regional Office for Europe update on avian influenza A (H7N9) virus WHO Regional Office for Europe update on avian influenza A (H7N9) virus Situation update 2: 30 April 2013 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO

More information

Guidelines for Animal Disease Control

Guidelines for Animal Disease Control Guidelines for Animal Disease Control 1. Introduction and objectives The guidelines are intended to help countries identify priorities, objectives and the desired goal of disease control programmes. Disease

More information

Are Booster Doses of Hepatitis B Vaccine Necessary?

Are Booster Doses of Hepatitis B Vaccine Necessary? Are Booster Doses of Hepatitis B Vaccine Necessary? Current CDC Recommendations And Gaps in Knowledge Division of Viral Hepatitis Centers for Disease Control and Prevention, USA Current United States Recommendations

More information

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT HIGHLIGHTS EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT SITUATION REPORT 3 OCTOBER 204 There have been 3 567 reported Ebola cases in eight affected countries since the outbreak began, with 495 reported

More information

CSCAP MEMORANDUM No. 15 The Security Implications of Climate Change

CSCAP MEMORANDUM No. 15 The Security Implications of Climate Change CSCAP MEMORANDUM No. 15 The Security Implications of Climate Change A Memorandum from the Council for Security Cooperation in the Asia Pacific (CSCAP) June 2010 CSCAP Memorandum No. 15 The Security Implications

More information

Thailand: National Immunization Program (NIP) Attaya Limwattanayingyong, MD, MSc 2 November 2015 Asian Pacific Vaccinology Meeting, BKK

Thailand: National Immunization Program (NIP) Attaya Limwattanayingyong, MD, MSc 2 November 2015 Asian Pacific Vaccinology Meeting, BKK Thailand: National Immunization Program (NIP) Attaya Limwattanayingyong, MD, MSc 2 November 2015 Asian Pacific Vaccinology Meeting, BKK Thailand Population: 68 mill. Pop. growth rate: 0.56% pa Birth rate:

More information

Immunisation. Immunisation

Immunisation. Immunisation Immunisation Immunisation Immunisation What is immunisation and why does my child need it? Immunisation is a simple, safe and effective way to protect children (and adults) from serious diseases. Immunisation

More information

FOR IMMEDIATE RELEASE Release #2014-04

FOR IMMEDIATE RELEASE Release #2014-04 FOR IMMEDIATE RELEASE Release #2014-04 CONTACT for this Release: Krista Dommer Office Phone: (209) 468-3571 Email: kdommer@sjcphs.org Alvaro Garza, MD, MPH. Public Health Officer MEASLES OUTBREAKS PROMPT

More information

Doing Business in Australia and Hong Kong SAR, China

Doing Business in Australia and Hong Kong SAR, China Doing Business in Australia and Hong Kong SAR, China Mikiko Imai Ollison Private Sector Development Specialist Nan Jiang Private Sector Development Specialist Washington, DC October 29, 2013 What does

More information

Guidelines for Vaccinating Pregnant Women

Guidelines for Vaccinating Pregnant Women Guidelines for Vaccinating Pregnant Women U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Disease Control & Prevention Guidelines for Vaccinating Pregnant Women from Recommendations of the Advisory

More information

Global Database on Blood Safety

Global Database on Blood Safety Global Database on Blood Safety Summary Report 2011 1 Key facts Global Blood Collection: Around 92 million blood donations are collected annually from all types of blood donors (voluntary unpaid, family/replacement

More information

Ad-hoc Virtual TAG Meeting 2016

Ad-hoc Virtual TAG Meeting 2016 Ad-hoc Virtual TAG Meeting 2016 XXIV Meeting of the Technical Advisory Group on Vaccine-preventable Diseases May 13, 2016 Washington, DC, USA 1 Table of Contents TABLE OF CONTENTS... 2 TAG MEMBERS... 3

More information

Pentavalent Vaccine. Guide for Health Workers. with Answers to Frequently Asked Questions

Pentavalent Vaccine. Guide for Health Workers. with Answers to Frequently Asked Questions Pentavalent Vaccine Guide for Health Workers with Answers to Frequently Asked Questions Ministry of Health and Family Welfare Government of India 2012 Immunization is one of the most well-known and effective

More information

CONTROL AND PREVENTION OF ENTERIC FEVER: POLICY AND PRACTICE IN WHO SEARO

CONTROL AND PREVENTION OF ENTERIC FEVER: POLICY AND PRACTICE IN WHO SEARO CONTROL AND PREVENTION OF ENTERIC FEVER: POLICY AND PRACTICE IN WHO SEARO Professor Lalitha Mendis 8 th International Conference on Typhoid fever And Other Invasive Salmonelloses 1-2 March 2013 WHO Position

More information

PARTICIPATION IN SEACEN TRAINING PROGRAMS

PARTICIPATION IN SEACEN TRAINING PROGRAMS PARTICIPATION IN SEACEN TRAINING PROGRAMS Participation in the training programs is by invitation. Participants of the training programs comprise mainly middle to senior level staff of the 20 SEACEN Regular

More information

Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians. December 14, 2009

Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians. December 14, 2009 Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians December 14, 2009 Table of Contents Preface... iii Significant Changes in the Vaccination Requirements... 1 Procedure

More information

THE USE OF COST BENEFIT ANALYSIS IN ANIMAL DISEASE CONTROL,

THE USE OF COST BENEFIT ANALYSIS IN ANIMAL DISEASE CONTROL, THE USE OF COST BENEFIT ANALYSIS IN ANIMAL DISEASE CONTROL, INCLUDING PRACTICAL EXAMPLES FROM THE REGION T. Carpenter 1 Original: English Keywords: animal disease control Asia cost benefit analysis An

More information

Joseph E. Zveglich, Jr.

Joseph E. Zveglich, Jr. Joseph E. Zveglich, Jr. Assistant Chief Economist, Asian Development Bank 1 Overseas Development Institute London, 12 April 2012 Key messages Developing Asia to maintain growth momentum despite weak global

More information

Unsafe abortion incidence and mortality

Unsafe abortion incidence and mortality Information sheet Information sheet Unsafe abortion incidence and mortality Global and regional levels in 08 and trends during 990 08 Unsafe abortion is defined by the World Health Organization (WHO) as

More information

Immunisation and Health Information for Health Care Workers and Others in At Risk Occupations

Immunisation and Health Information for Health Care Workers and Others in At Risk Occupations Chapter 4 Occupations 04 Information for Health Care Workers and Others in At Risk Occupations Introduction Workers in a variety of occupations may be exposed to infectious agents during their employment.

More information

Frequently asked questions (FAQs) FAQs for travellers from polio-infected countries

Frequently asked questions (FAQs) FAQs for travellers from polio-infected countries Frequently asked questions (FAQs) FAQs for travellers from polio-infected countries Why has the WHO Director-General made these recommendations for travellers and why now? In January 2014, governments

More information

Thailand and ASEAN. 1. ASEAN: Forty Five Years of Achievements

Thailand and ASEAN. 1. ASEAN: Forty Five Years of Achievements Thailand and ASEAN 1. ASEAN: Forty Five Years of Achievements Since its inception in 1967, the Association of Southeast Asian Nations (ASEAN) has made a number of achievements towards regional peace, stability,

More information

cambodia Maternal, Newborn AND Child Health and Nutrition

cambodia Maternal, Newborn AND Child Health and Nutrition cambodia Maternal, Newborn AND Child Health and Nutrition situation Between 2000 and 2010, Cambodia has made significant progress in improving the health of its children. The infant mortality rate has

More information

The Effective Vaccine Management Initiative Past, Present and Future

The Effective Vaccine Management Initiative Past, Present and Future EVM setting a standard for the vaccine supply chain The Effective Vaccine Management Initiative Past, Present and Future Paul Colrain TechNet meeting Dakar, Senegal, February 2013 February 2013 TechNet

More information

disasters Natural Figure 29.1

disasters Natural Figure 29.1 29 Natural disasters Many parts of Asia and the Pacific have seen their economic and social development stalled, or even reversed, by natural disasters. Across the region, people have lost their assets,

More information